Recent Updates
Recently added Catalysts
ACIU

AC Immune Kol Webinar on First Clinical Proof of Concept For Alpha Synuclein Diagnostic Shows Breakthrough Potential For Neurodegenerative Diseases

Wednesday, March 30, 2022 1 min read
Key Takeaway: AC Immune Kol Webinar on First Clinical Proof of Concept For Alpha Synuclein Diagnostic Shows Breakthrough Potential For Neurodegenerative Diseases

Full Press Release Details

AC Immune Kol Webinar on First Clinical Proof of Concept For Alpha Synuclein Diagnostic Shows Breakthrough Potential For Neurodegenerative Diseases.
Tags: ACIU Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Mar 30, 2022